BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Evangelisti C, Chiarini F, McCubrey JA, Martelli AM. Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update. Int J Mol Sci 2018;19:E1878. [PMID: 29949919 DOI: 10.3390/ijms19071878] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Sampagar A, Chakrala R, Kamate M. Rare Association of Tuberous sclerosis with Acute Lymphoblastic Leukemia: Case Report with Review of Literature. Indian J Med Paediatr Oncol. [DOI: 10.1055/s-0042-1743126] [Reference Citation Analysis]
2 Pham LT, Peng H, Ueno M, Kohno S, Kasada A, Hosomichi K, Sato T, Kurayoshi K, Kobayashi M, Tadokoro Y, Kasahara A, Shoulkamy MI, Xiao B, Worley PF, Takahashi C, Tajima A, Hirao A. RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia. Biochem Biophys Res Commun 2022;621:74-9. [PMID: 35810594 DOI: 10.1016/j.bbrc.2022.06.089] [Reference Citation Analysis]
3 Tang X, Chen F, Xie LC, Liu SX, Mai HR. Targeting metabolism: A potential strategy for hematological cancer therapy. World J Clin Cases 2022; 10(10): 2990-3004 [DOI: 10.12998/wjcc.v10.i10.2990] [Reference Citation Analysis]
4 Silic-benussi M, Sharova E, Ciccarese F, Cavallari I, Raimondi V, Urso L, Corradin A, Kotler H, Scattolin G, Buldini B, Francescato S, Basso G, Minuzzo SA, Indraccolo S, D'agostino DM, Ciminale V. mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells. Redox Biology 2022. [DOI: 10.1016/j.redox.2022.102268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu Y, Fang B, Feng X, Jiang Y, Zeng Y, Jiang J. Mechanism of IDH1-R132H mutation in T cell acute lymphoblastic leukemia mouse model via the Notch1 pathway. Tissue Cell 2021;74:101674. [PMID: 34814054 DOI: 10.1016/j.tice.2021.101674] [Reference Citation Analysis]
6 Zeng L, Tang M, Pi C, Zheng J, Gao S, Chabanne T, Chauvin R, Cheng W, Lin H, Xu R, Cui X. Novel Ferrocene Derivatives Induce Apoptosis through Mitochondria-Dependent and Cell Cycle Arrest via PI3K/Akt/mTOR Signaling Pathway in T Cell Acute Lymphoblastic Leukemia. Cancers (Basel) 2021;13:4677. [PMID: 34572904 DOI: 10.3390/cancers13184677] [Reference Citation Analysis]
7 Tosello V, Bongiovanni D, Di Martino L, Franchin C, Zanovello P, Arrigoni G, Piovan E. Responsiveness to Hedgehog Pathway Inhibitors in T-Cell Acute Lymphoblastic Leukemia Cells Is Highly Dependent on 5'AMP-Activated Kinase Inactivation. Int J Mol Sci 2021;22:6384. [PMID: 34203724 DOI: 10.3390/ijms22126384] [Reference Citation Analysis]
8 Olivas-Aguirre M, Torres-López L, Pottosin I, Dobrovinskaya O. Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol. Front Oncol 2021;11:617937. [PMID: 33777761 DOI: 10.3389/fonc.2021.617937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mroczek A, Zawitkowska J, Kowalczyk J, Lejman M. Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia. Int J Mol Sci 2021;22:E808. [PMID: 33467425 DOI: 10.3390/ijms22020808] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Kong D, Fan S, Sun L, Chen X, Zhao Y, Zhao L, Guo Z, Li Y. Growth inhibition and suppression of the mTOR and Wnt/β-catenin pathways in T-acute lymphoblastic leukemia by rapamycin and MYCN depletion. Hematol Oncol 2021;39:222-30. [PMID: 33300153 DOI: 10.1002/hon.2831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Santos-Pirath ÍM, Walter LO, Maioral MF, Pacheco LA, Sens L, Nunes RJ, Santos-Silva MC. Molecular events and cytotoxic effects of a novel thiosemicarbazone derivative in human leukemia and lymphoma cell lines. Hematol Oncol Stem Cell Ther 2021;14:51-64. [PMID: 32763229 DOI: 10.1016/j.hemonc.2020.07.007] [Reference Citation Analysis]
12 Bonaccorso P, Bugarin C, Buracchi C, Fazio G, Biondi A, Lo Nigro L, Gaipa G. Single‐cell profiling of pediatric T‐cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K / Akt and JAK–STAT signaling pathways. Cytometry 2020;98:491-503. [DOI: 10.1002/cyto.b.21882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Liu J, Liu P, Xu T, Chen Z, Kong H, Chu W, Wang Y, Liu Y. Berberine Induces Autophagic Cell Death in Acute Lymphoblastic Leukemia by Inactivating AKT/mTORC1 Signaling. Drug Des Devel Ther 2020;14:1813-23. [PMID: 32494123 DOI: 10.2147/DDDT.S239247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Payne JL, Song C, Ding Y, Dhanyamraju PK, Bamme Y, Schramm JW, Desai D, Sharma A, Gowda C, Dovat S. Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci 2020;21:E1718. [PMID: 32138279 DOI: 10.3390/ijms21051718] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Fattizzo B, Rosa J, Giannotta JA, Baldini L, Fracchiolla NS. The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects. Front Oncol 2020;10:273. [PMID: 32185137 DOI: 10.3389/fonc.2020.00273] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
16 Chiarini F, Paganelli F, Martelli AM, Evangelisti C. The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia. Int J Mol Sci 2020;21:E1098. [PMID: 32046053 DOI: 10.3390/ijms21031098] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
17 Evangelisti C, Chiarini F, Cappellini A, Paganelli F, Fini M, Santi S, Martelli AM, Neri LM, Evangelisti C. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia. J Cell Physiol 2020;235:5413-28. [PMID: 31904116 DOI: 10.1002/jcp.29429] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
18 Cuomo F, Altucci L, Cobellis G. Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy. Cancers (Basel) 2019;11:E1465. [PMID: 31569540 DOI: 10.3390/cancers11101465] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
19 Paganelli F, Lonetti A, Anselmi L, Martelli AM, Evangelisti C, Chiarini F. New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia. Adv Biol Regul 2019;74:100649. [PMID: 31523031 DOI: 10.1016/j.jbior.2019.100649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Dormond O. mTOR in Human Diseases. Int J Mol Sci 2019;20:E2351. [PMID: 31083592 DOI: 10.3390/ijms20092351] [Reference Citation Analysis]
21 Martelli AM, Paganelli F, Fazio A, Bazzichetto C, Conciatori F, McCubrey JA. The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response. Cancers (Basel) 2019;11:E629. [PMID: 31064074 DOI: 10.3390/cancers11050629] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
22 Lorentzian A, Uzozie A, Lange PF. Origins and clinical relevance of proteoforms in pediatric malignancies. Expert Rev Proteomics 2019;16:185-200. [PMID: 30700156 DOI: 10.1080/14789450.2019.1575206] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Chiarini F, Evangelisti C, Cenni V, Fazio A, Paganelli F, Martelli AM, Lattanzi G. The Cutting Edge: The Role of mTOR Signaling in Laminopathies. Int J Mol Sci 2019;20:E847. [PMID: 30781376 DOI: 10.3390/ijms20040847] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
24 Mirabilii S, Ricciardi MR, Piedimonte M, Gianfelici V, Bianchi MP, Tafuri A. Biological Aspects of mTOR in Leukemia. Int J Mol Sci 2018;19:E2396. [PMID: 30110936 DOI: 10.3390/ijms19082396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]